Medical guidelines
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive SummaryDaley C L, Iaccarino J M, Jr, Lange C, et al. Clin. Infect. Dis. 2020 doi:10.1093/cid/ciaa241
EUCAST
- EUCAST evaluation of 21 brands of Mueller-Hinton dehydrated media for disk diffusion testing.
Åhman J, Matuschek E, Kahlmeter G. Clin Microbiol Infect 2020. doi: 10.1016/j.cmi.2020.01.018. - EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin.
Skov R, Varga A, Matuschek E, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.05.002. - The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles.
Jonasson E, Matuschek E, Kahlmeter G. J Antimicrob Chemother 2020. doi: 10.1093/jac/dkz548. - Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) position statements on polymyxin B and colistin clinical breakpoints.
Satlin MJ, Lewis JS, Weinstein MP, et al. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa121. - A multiplex fluidic chip for rapid phenotypic antibiotic susceptibility testing.
Wistrand-Yuen P, Malmberg C, Fatsis-Kavalopoulos N, et al. mBio 2020 doi: 10.1128/mBio.03109-19. - Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper.
Turnidge J, Kahlmeter G, Cantón R, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2020.04.027.
EITaF
- MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Battista Migliori G, Tiberi S, Zumla A, et al. Int J Infect Dis 2020. pii: S1201-9712(20)30045-X. doi: 10.1016/j.ijid.2020.01.042.
- 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.
Albarello F, Pianura E, Di Stefano F, et al. Int J Infect Dis 2020 pii: S1201-9712(20)30101-6. doi: 10.1016/j.ijid.2020.02.043. - Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic.
Tiberi S, Migliori GB, Muhwa Chakaya J, et al. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2020.03.001. - Transmission of respiratory tract infections at mass gathering events.
Petersen E, Memish ZA, Zumla A, Maani AA. Curr Opin Pulm Med 2020 doi: 10.1097/MCP.0000000000000675. - COVID-19, SARS and MERS: are they closely related?
Petrosillo N, Viceconte G, Ergonul O, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2020.03.026. - SARS-CoV-2 epidemiology and control, different scenarios for Turkey
Petersen E, Gökengin D. Turk J Med Sci 2020 doi: 10.3906/sag-2003-260. - COVID-19 travel restrictions and the International Health Regulations - Call for an open debate on easing of travel restrictions.
Petersen E, McCloskey B, Hui DS, et al. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2020.04.029. - COVID-19-We urgently need to start developing an exit strategy.
Petersen E, Wasserman S, Lee SS, Int J Infect Dis 2020 doi: 10.1016/j.ijid.2020.04.035.
EUCIC
- Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study. Birgand G, Mutters NT, Ahmad R, et al. Antimicrob Resist Infect Control. 2020;9(1):33. doi: 10.1186/s13756-020-0695-z.
Position Papers
- Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Tabah A, Bassetti M, Kollef MH, et al. Intensive Care Med 2020 doi: 10.1007/s00134-019-05866-w. - EHRA international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the HRS, APHRS, LAHRS, ISCVID and the ESCMID in collaboration with the EACTS
Blomström-Lundqvist C, Traykov V, Erba PA et al. Eur J Cardiothorac Surg. 2020 doi: 10.1093/ejcts/ezz296. - Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
Boettler T, Newsome PN, Mondelli MU, et al. JHEP Rep 2020 doi: 10.1016/j.jhepr.2020.100113.
Publications from study groups
EFISG
- Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP‐EBMT, EORTC‐IDG, SEIFEM survey
Lanternier F, Seidel D, Pagano L, et al. Mycoses 2020. doi: 10.1111/myc.13056
EFWISG
- Food-to-Humans Bacterial Transmission.
Antunes P, Novais C, Peixe L. Microbiol Spectr 2020;8(1). doi: 10.1128/microbiolspec.MTBP-0019-2016.
ESGAI
- A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects.
Sóki J, Wybo I, Hajdú E, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2020.102182. - Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study.
Veloo ACM, Tokman HB, Jean-Pierre H, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2019.102111.
ESGB
- Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
Allkjaa J, Bjarnsholt T, Coenye T, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100010 - The future of biofilm research – Report on the ‘2019 Biofilm Bash’
Coenye T, Kjellerup B, Stoodley P, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100012.
ESGBIES
- Bloodstream infections - Standard and progress in pathogen diagnostics.
Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.11.017.
ESGBOR
- Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
Raffetin A, Saunier A, Bouiller K, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.06.033. - Rejection of the name Borreliella and all proposed species comb. nov. placed therein.
Margos G, Castillo-Ramirez S, Cutler S, et al. Int J Syst Evol Microbiol 2020 doi: 10.1099/ijsem.0.004149.
ESGCD
- The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
Novakova E, Stefkovicova M, Kopilec MG, et al. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2019.10.038. - Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
Freeman J, Vernon J, Pilling S, et al. Eur J Clin Microbiol Infect Dis 2020 doi: 10.1007/s10096-019-03708-7.
ESGCP
- Child health, parasites and lower socioeconomic status: Outcomes of a long-term screening, intervention and training study by health volunteers in rural Nepal.
Sürmeli A, Tolunay T, Yasin Y, et al. Acta Trop 2020 doi: 10.1016/j.actatropica.2019.105263. - Imported malaria in semi-immune and non-immune travelers in non-malaria-endemic countries. Mischlinger J, Rönnberg C, Álvarez-Martínez M, et al. Clin Microbiol Rev 2020. doi: 10.1128/CMR.00104-19.
- Toxoplasma gondii-specific IgG avidity testing in pregnant women.
Garnaud C, Fricker-Hidalgo H, Evengård B, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2020.04.014.
ESGIAI
- Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171. - Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020 doi: 10.1007/s10096-020-03852-5.
ESGIB
- Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study.
Popescu CP, Florescu SA, Hasbun R, et al. J Clin Virol. 2020 doi: 10.1016/j.jcv.2019.104213. - A Prospective Cohort Study to Identify Clinical, Biological and Imaging Features That Predict Etiology of Acute Encephalitis
Le Maréchal M, Mailles A, Seigneurin A et al. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa598.
ESGIE
- Considerations for the optimal management of antibiotic therapy in elderly patients.
Falcone M, Paul M, Tiseo G, et al. J Glob Antimicrob Resist 2020 doi: 10.1016/j.jgar.2020.02.022.
ESGITM
- Parasitic skin infections: neglected diseases or just challenging for diagnosis?
Gardini G, Tomasoni LR, Castelli F. Curr Opin Infect Dis 2020. doi: 10.1097/QCO.0000000000000634.
ESGLI
- A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex.
Ginevra C, Chastang J, David S et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.09.002.
ESGMAC
- Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.
Beeton ML, Zhang XS, Uldum SA, et al. Euro Surveill 2020 doi: 10.2807/1560-7917.ES.2020.25.2.1900112.
ESGMD
- Core/whole genome multilocus sequence typing and core genome SNP-based typing of OXA-48-producing Klebsiella pneumoniae clinical isolates from Spain.
Miro E, Rossen JWA, Chlebowicz MA, et al. Front Microbiol 2020 doi: 10.3389/fmicb.2019.02961.
ESGREV
Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives
Nelson PP, Rath BA, Fragkou PC et al Front Cell Infect Microbiol 2020 doi: 10.3389/fcimb.2020.00181
ESGS
- Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
Wirth T, Bergot M, Rasigade JP, et al. Nat Microbiol 2020 doi: 10.1038/s41564-020-0676-2.
ESGVH
- Elimination of hepatitis C in Europe: can WHO targets be achieved?
Maticic M, Lombardi A, Mondelli MU, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2020.01.014.
ESGBIES & ESGICH
- A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa (IRONIC study).
Gudiol C, Albasanz-Puig A, Laporte-Amargós J, et al. Antimicrob Agents Chemother 2020 pii: AAC.02494-19. doi: 10.1128/AAC.02494-19.
ESGMYC & ESGITM & EITaF
- Tools to implement the WHO End TB Strategy: Addressing common challenges in high and low endemic countries.
Al Abri S, Kasaeva T, Migliori GB, et al. Int J Infect Dis. 2020 pii: S1201-9712(20)30100-4. doi: 10.1016/j.ijid.2020.02.042.
Publications from recipients (*) of ESCMID Research Grants
- Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
Beredaki MI, Georgiou PC, Siopi M, Kanioura L, Arendrup MC, Mouton JW, Meletiadis J*. J Antimicrob Chemother 2020 doi: 10.1093/jac/dkz425. - Comparative Transcriptomics Reveals Clues for Differences in Pathogenicity between Hysterothylacium aduncum, Anisakis simplex sensu stricto and Anisakis pegreffii.
Cavallero S*, Lombardo F, Salvemini M, et al. Genes (Basel) 2020 doi: 10.3390/genes11030321.
